Fasting used to enhance cancer treatment for patients who are immunocompromised and/or undergoing treatment
Other Title(s)
The benefits of fasting used to enhance cancer treatment for patients who are immunocompromised and/or undergoing treatment;
Rising Star Poster
Rising Star Poster
View File(s)
Author Information
- Author(s)
- Details
-
Lorena C. Burnett, BS, RN-BC, E7 Oncology, Covenant Medical Center, Lubbock, Texas, USA
- Sigma Affiliation
- Non-member
- Contributor Affiliation(s)
- Covenant Medical Center, Lubbock, Texas, USA
Item Information
Item Link - Use this link for citations and online mentions.
Abstract
This review aims to answer the question of whether fasting will help protect the immune system against the toxicity of cancer treatment and increase efficacy of treatment as well as decreasing some of the side effects.
Repository Posting Date
2021-03-12T01:02:54Z
Type Information
| Type | Poster |
| Acquisition | Proxy-submission |
| Review Type | None: Event Material, Invited Presentation |
| Format | Text-based Document |
Category Information
| Evidence Level | Literature Review |
| Research Approach | N/A |
| Keywords | Chemotherapy; Fasting; Immune System |
Conference Information
| Name | Creating Healthy Work Environments 2021 |
| Host | Sigma Theta Tau International |
| Location | Virtual Event |
| Date | 2021 |
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Related items
Showing items related by title, author, creator and subjects.
-
Evaluation of the implementation of ASPAN's evidence-based clinical practice guideline for the prevention and/or treatment of postoperative nausea and vomiting
(2016-03-17)Session presented on Friday, July 24, 2015: Evaluation of the Implementation of the ASPAN's Evidence-Based Clinical Practice Guideline for the Prevention and/or Treatment of Postoperative Nausea and Vomiting Lisa Stephens ... -
Elderly partners' lived experience of bladder and/or colorectal cancer diagnosis living with a ostomy
Bladder and colorectal cancer (CRC) are two of the most aggressive types of cancer with treatment creating physical and psychosocial comorbidities that affect the quality of life of patients affected by the disease. Numerous ... -
Factors associated with high dose Benzodiazepines use in long-term users with depressive and/or anxiety disorders
We expect the findings draw attendees' attention on the high dose of benzodiazepines (BZDs) use among this population and its risk factors, and providing information for healthcare providers to develop additional strategies ... -
Examining the use of the transdermal scopolamine patch in the prevention of postdischarge nausea and/or vomiting: A secondary analysis
(2016-03-21)Session presented on Sunday, November 8, 2015: Postdischarge nausea and/or vomiting (PDNV) is estimated to affect up to 50% of patients undergoing general anesthesia. New guidelines recommend long acting antiemetics for ... -
Increasing awareness: Does early childhood drug education provide diversion from using drugs and/or alcohol?
(2018-07-03)In the U.S., nearly 2,200 youth (ages 12 - 17) abuse prescription painkillers each day with illegal drug use being the second leading cause of accidental death for this age group. Research supports school-based education ...
